SEC Form 4 · accession 0001127602-15-012775

ARIAD PHARMACEUTICALS INC · ARIA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Mar 26, 2015

Accepted (ET)

Mar 30, 2015 · 4:21 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000884731

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 26, 2015	M	26,454	$7.56	A	1,347,108	D
Common Stock	Mar 26, 2015	F	24,479	$8.17	D	1,322,629	D
Common Stock	Mar 26, 2015	M	12,544	$7.56	A	1,335,173	D
Common Stock	Mar 26, 2015	M	111,002	$7.56	A	1,446,175	D
Common Stock	Mar 26, 2015	F	102,715	$8.17	D	1,343,460	D
Common Stock	holding	—	—		—	246,054	I	Daughter
Common Stock	holding	—	—		—	248,745	I	Daughter
Common Stock^F3	holding	—	—		—	1,864,286	I	Ocean Capital Partners, Llc
Common Stock	holding	—	—		—	245,251	I	Wife

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (Right to Buy)	$7.56	Mar 26, 2015	M	26,454	D	Oct 4, 2006	Oct 4, 2015	Common Stock	26,454	D
Employee Stock Option (Right to Buy)	$7.56	Mar 26, 2015	M	12,544	D	Oct 4, 2006	Oct 4, 2015	Common Stock	12,544	D
Employee Stock Option (Right to Buy)	$7.56	Mar 26, 2015	M	111,002	D	Oct 4, 2006	Oct 4, 2015	Common Stock	111,002	D

F1Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
F2Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options and to satisy withholding tax requirements.
F3The reporting person is a managing member of this LLC.